Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners
The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.
-
(2008/12/05)
More Articles about upstream products of 1009093-53-1